Multiparametric magnetic resonance imaging (MRI) represents the most accurate imaging modality for prostate cancer imaging to date.
Transrectal ultrasound (TRUS) is easily applied and therefore remains the gold standard for systematic prostate biopsies. However, the advantages of both modalities can be combined by image fusion. Currently, several image fusion devices are being implemented into clinical routine. First data show an increased detection rate of prostate cancer compared to systematic TRUS biopsies. At present prostatic deformation and intracorporeal movement represent technical challenges yet to be overcome. The present article gives an overview about the status of MRI-based biopsy techniques and highlights the current studies on the topic.
Written by:
Schilling D, Kurosch M, Mager R, Tsaur I, Haferkamp A, Röthke M. Are you the author?
Klinik für Urologie und Kinderurologie, Universitätsklinikum Frankfurt am Main, Theodor-Stern-Kai 7, 90690, Frankfurt am Main, Deutschland.
Reference: Urologe A. 2013 Apr;52(4):481-9.
doi: 10.1007/s00120-012-3096-y
PubMed Abstract
PMID: 23483269
Article in German.
UroToday.com Prostate Cancer Section
